ITEM 5 - MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
−Removed: Our common stock was previously listed on Nasdaq under the symbol “MNLO” since January 24, 2018 until it changed to "VYNE" in connection with the corporate name change on September 4, 2020.
−Removed: Prior to January 24, 2018, there was no public trading market for our common stock.
+Added: Our common stock is listed on Nasdaq under the symbol “VYNE.”
On February 10, 2021, our Board of Directors approved a one-for-four reverse stock split of our outstanding shares of common stock.
3 unchanged sentences
No fractional shares were issued in connection with the reverse stock split, and in lieu thereof, each stockholder holding fractional shares was entitled to receive a cash payment (without interest or deduction) from the Company’s transfer agent in an amount equal to such stockholder’s respective pro rata shares of the total net proceeds from the Company’s transfer agent sale of all fractional shares at the then-prevailing prices on the open market.
−Removed: In connection with the reverse stock split, the number of authorized shares of our common stock was also reduced on a one-for-four basis, from 300 million to 75 million.
The par value of each share of common stock remained unchanged.
1 unchanged sentence
Holders of Common Stock
−Removed: As of February 25, 2020, there were approximately 8 holders of record of our common stock.
+Added: As of March 2, 2022, there were approximately 8 holders of record of our common stock.
This number does not include beneficial owners whose shares are held by nominees in street name.
−Removed: ITEM 6 - SELECTED FINANCIAL DATA
−Removed: Removing and reserving Item 6.
+Added: ITEM 6 - [RESERVED]
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.